Add Company
Join Now

Ascletis Revenue and Competitors

License our Company Data API

杭州市,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Ascletis's estimated annual revenue is currently $8M per year.(i)
  • Ascletis's estimated revenue per employee is $201,000

Employee Data

  • Ascletis has 40 Employees.(i)
  • Ascletis grew their employee count by -2% last year.

Ascletis's People

NameTitleEmail/Phone
1
VP OperationsReveal Email/Phone
2
vp corporate affairsReveal Email/Phone
3
Director Regulatory AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Ascletis?

歌礼生物科技(杭州)有限公司

keywords:N/A

N/A

Total Funding

40

Number of Employees

$8M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ascletis News

2022-04-17 - Ascletis Announces 3CLpro Inhibitor ASC11 Demonstrated ...

HANGZHOU, China and SHAOXING, China, April 19, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that its oral small...

2022-04-17 - Ascletis' oral drug shows potential for Covid-19 treatment

Ascletis Pharma has reported that its oral small molecule drug candidate ASC11 showed potential for the treatment of Covid-19.

2022-04-13 - Ascletis Announces Cooperation with China Meheco ...

for distribution of its ritonavir tablets in Chinese mainland. Ascletis Pharmaceuticals is a wholly-owned subsidiary of Ascletis, and China...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.6M48-4%N/A
#2
$11.5M48-6%N/A
#3
$14.3M59-20%N/A
#4
$10.2M6612%N/A
#5
$25.6M102-6%N/A